Works matching IS 16639812 AND DT 2016 AND VI 6


Results: 21
    1
    2

    Physiological and Pathophysiological Insights of Nav1.4 and Nav1.5 Comparison.

    Published in:
    Frontiers in Pharmacology, 2016, v. 6, p. 1, doi. 10.3389/fphar.2015.00314
    By:
    • Loussouarn, Gildas;
    • Sternberg, Damien;
    • Nicole, Sophie;
    • Marionneau, Céline;
    • Le Bouffant, Francoise;
    • Toumaniantz, Gilles;
    • Barc, Julien;
    • Malak, Olfat A.;
    • Fressart, Véronique;
    • Péréon, Yann;
    • Baró, Isabelle;
    • Charpentier, Flavien
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    The Human Experience with Intravenous Levodopa.

    Published in:
    Frontiers in Pharmacology, 2016, v. 6, p. 1, doi. 10.3389/fphar.2015.00307
    By:
    • Siddiqi, Shan H.;
    • Abraham, Natalia K.;
    • Geiger, Christopher L.;
    • Karimi, Morvarid;
    • Perlmutter, Joel S.;
    • Black, Kevin J.;
    • Doudet, Doris;
    • Saha, Kaustuv
    Publication type:
    Article
    19

    Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study.

    Published in:
    Frontiers in Pharmacology, 2016, v. 6, p. 1, doi. 10.3389/fphar.2015.00299
    By:
    • Toth, Peter P.;
    • Patti, Angelo M.;
    • Nikolic, Dragana;
    • Giglio, Rosaria V.;
    • Castellino, Giuseppa;
    • Biancucci, Teresa;
    • Geraci, Fabiana;
    • David, Sabrina;
    • Montalto, Giuseppe;
    • Rizvi, Ali;
    • Rizzo, Manfredi;
    • Tibullo, Daniele;
    • Bramanti, Vincenzo
    Publication type:
    Article
    20
    21